Low Dose Naltrexone for the Treatment of Fibromyalgia
In our study, 28 women with fibromyalgia took one pill a day for 16 weeks. During that time, each woman took the LDN (4.5 mg) for 12 weeks and a sugar pill (placebo) for 4 weeks. The study was double-blind, meaning that neither the women participating in the study nor the healthcare team knew which pill they were taking at any time. Each woman was given a handheld computer to record their pain, fatigue, and other symptoms on a daily basis, and they continued to record their symptoms for 4 weeks after they stopped taking the capsules.
The results of the study were similar to the results of our earlier, smaller study—participants experienced a significantly greater reduction in their pain scores while they were taking the LDN as compared with while placebo. They also reported improved general satisfaction with life and improved mood while taking LDN. However, there was no improvement in fatigue or sleep. All participants tolerated the LDN, with few side effects.
Our Motto at LDNIM.. If it's good enough for Stanford, it's good enough for us. Seriously, this study is significant because it spreads the importance of LDN to treat not only Fibromyalgia, but in treating other autoimmune diseases. The more we spread the word about Low Dose Naltrexone, the more commonly accepted it will be by patients and doctors. Together we can treat autoimmune diseases and create a healthier lifestyle.